[Ask more of an antibiotic to obtain the least]

[Article in French]

Review

[Article in French]

Philippe Letonturier. Presse Med. 2005.

. 2005 May 14;34(9):690-1.

doi: 10.1016/s0755-4982(05)84016-3.

No abstract available

Similar articles

Recent trends in antimicrobial resistance among Streptococcus pneumoniae and Staphylococcus aureus isolates: the French experience.
Anonymous. Anonymous. Euro Surveill. 2008 Nov 13;13(46):19035. Euro Surveill. 2008. PMID: 19021955
In-vitro activity of quinupristin/dalfopristin (Synercid) against isolates of Streptococcus pneumoniae, Staphylococcus aureus and enterococcus spp.
Johnson AP, Warner M, Speller DC. Johnson AP, et al. J Antimicrob Chemother. 1997 Oct;40(4):604-5. doi: 10.1093/jac/40.4.604. J Antimicrob Chemother. 1997. PMID: 9372437 No abstract available.
Back into the wild: how resistant pathogens become susceptible again?
Kernéis S, Valade S, Woerther PL. Kernéis S, et al. Intensive Care Med. 2020 Feb;46(2):361-363. doi: 10.1007/s00134-020-05932-8. Epub 2020 Feb 3. Intensive Care Med. 2020. PMID: 32016533 No abstract available.
Antimicrobial-resistant pathogens in the 1990s.
Jacoby GA. Jacoby GA. Annu Rev Med. 1996;47:169-79. doi: 10.1146/annurev.med.47.1.169. Annu Rev Med. 1996. PMID: 8712771 Review.
Antibiotic resistance in Staphylococcus aureus and streptococci.
Lacey RW. Lacey RW. Br Med Bull. 1984 Jan;40(1):77-83. doi: 10.1093/oxfordjournals.bmb.a071951. Br Med Bull. 1984. PMID: 6442875 Review. No abstract available.